Share this post: ×

Webinar: Sex, Drugs, and Rock & Roll – Modern Day Head and Neck Cancer

Date and Time:  Wednesday, November 13 at 4:00 PM Pacific (7:00 pm Eastern)

Webinar Description:  

Head and neck cancer that is positive for the human papillomavirus (HPV+) represents a disease with increasing incidence, but better prognosis, compared to non-HPV related disease. This webinar will discuss:

  • the pathogenesis and epidemiology of HPV+ head and neck cancer
  • the management of HPV+ head and neck cancer
  • de-intensification strategies to improve long-term function
  • immunotherapy efficacy in HPV+ head and neck cancer 

Cost: This webinar is FREE thanks to the generosity of an unrestricted educational grant from Bracco Diagnostics. The National Foundation of Swallowing Disorders is a non-profit organization that relies on the financial support of our sponsors and community members. 100% of donations received by webinar registrants will be directed towards head and neck cancer-related dysphagia research.

No ASHA CEUs will be offered for this webinar.


Meet the Presenter: Ezra Cohen, MD, FRCPSC, FASCO. Ezra Cohen is co‐Director of the San Diego Center for Precision Immunotherapy and an internationally renowned translational researcher. A physician‐scientist, Dr. Cohen led an independently funded laboratory interested in mechanisms of action of novel therapeutics. He has made major contributions to targeted and immunotherapy. His research has received peer‐reviewed funding in the study of epidermal growth factor receptor inhibitors, cell therapy, and immunotherapy in head and neck cancer. He has made major contributions to the understanding of critical signaling pathways, integration of novel agents into standard of care, and definition of mechanisms to overcome resistance to drug therapy. He has also recently co‐developed a personalized neoantigen vaccine using unique cancer mutations to boost an anti‐tumor immune response.

Dr. Cohen is Associate Director for Translational Science and leader of the Solid Tumor Therapeutics research program at Moores Cancer Center. He brings his expertise and preeminent reputation in head and neck cancer research and patient care to solid tumor therapeutics. Among other roles, he is chair of the Protocol Review and Monitoring Committee (PRMC) and serves as a member of the Cancer Council, and the Cancer Center’s Executive Committee.

Dr. Cohen recently served as editor‐in‐chief of Oral Oncology, the highest impact specialty journal in head and neck cancer, and currently serves as senior editor for Clinical Cancer Research. He has been the principal investigator on multiple studies of novel agents in head and neck cancer and other solid tumors in all phases of development including chemo prevention, phase I, II, and III trials. Dr. Cohen has authored more than 170 papers and has presented his research at national and international meetings. In addition, he has served as a grant reviewer for the NIH, American Association for Cancer Research, American Society of Clinical Oncology, and the Ontario Institute for Cancer Research.

Dr. Cohen completed residencies in Family Medicine at the University of Toronto and in Internal Medicine at Albert Einstein College of Medicine. He completed a Hematology/Oncology fellowship at the University of Chicago where he was named chief fellow. Prior to his arrival in San Diego, Dr. Cohen was Co‐Director of the Head and Neck Cancer Program, Associate Director for Education and Program Director for the Hematology/Oncology Fellowship at the University of Chicago Comprehensive Cancer Center. A dedicated educator, Dr. Cohen also mentored and developed young faculty in his program.

____________

Medical disclaimer. This Webinar is for informational purposes only and should not be used as a substitute for consultation with an appropriate health care professional, as each individual’s medical situation is unique. It is important that you consult with your medical professional (e.g., physician, SLP) before implementing any course of treatment. Experiences that are new to you should be done with the help of a caregiver and when access to emergency medical care is available.



Share this post: ×

Webinar: Dysphagia’s Broader Impacts on Caregivers & Families

Date and Time:  Thursday, October 17 at 4:00 PM Pacific (7:00 pm Eastern)

Webinar Description:  

Dysphagia’s biopsychosocial ramifications are widespread, impacting nearly every facet of an individual’s life. However, often overlooked is the influence of dysphagia on informal caregivers and families. Ultimately, the health and well-being of the entire family is central to care provision outcomes; when one member of a family system faces a chronic health condition, the entire family is simultaneously and reciprocally impacted. The first portion of this presentation will introduce attendees to the current literature on dysphagia-related third-party disability and caregiver burden, presenting two interdisciplinary models that can guide more family-focused, comprehensive approaches to care. Attendees will then be provided with a first-hand description of the lived experience of being a family member of a stroke survivor with dysphagia, including (potentially unexpected) challenges and factors that can contribute to a family’s resiliency. Geared toward professionals, patients, and families, at the conclusion of this presentation, all attendees will be more informed of the necessity of moving beyond impairment-level approaches to treatment in order to maximize healthcare outcomes for patients and their families.

Cost: FREE. This webinar is free to all registrants thanks to an unrestricted educational grant provided by Bracco Diagnostics.

No ASHA CEUs will be offered for this webinar.

Meet the Presenters: 

Samantha Shune, PhD, CCC-SLP. Samantha is an assistant professor at the University of Oregon. Her research and clinical interests include the effects of healthy and pathologic aging on swallowing and the mealtime process. She is particularly interested in better understanding shared food-related activities as opportunities to therapeutically target improved quality of life for both older adults and their social networks (e.g., partners, family members). Prior to returning to school for her PhD and throughout her doctoral program, she worked as an ASHA certified speech-language pathologist in various medical settings (inpatient/outpatient rehabilitation, skilled nursing, acute care), with a particular focus on dysphagia and stroke rehabilitation. In addition to her research, she currently teaches in the area of medical speech-language pathology and organizes a swallowing disorders support group. More information about her work is available at https://eatinglab.uoregon.edu

Michele Vandehey, MS, CCC-SLP. Michelle is an acute care speech-language pathologist. She completed her coursework and thesis in dysphagia at Idaho State University under the direction and guidance of Dr. Tony Seikel. She is also the daughter of a stroke survivor with severe dysphagia who she provided support to within the home and community for nearly 20 years. Her clinical and research interests primarily center on identifying dysphagia and its impact on individuals and their families, including how to foster improved functional outcomes. 

____________

Medical disclaimer. This Webinar is for informational purposes only and should not be used as a substitute for consultation with an appropriate health care professional, as each individual’s medical situation is unique. It is important that you consult with your medical professional (e.g., physician, SLP) before implementing any course of treatment. Experiences that are new to you should be done with the help of a caregiver and when access to emergency medical care is available.



Share this post: ×

Webinar Recording: Parkinson’s Disease & Swallowing



Share this post: ×

Research Opportunity

Nova Southeastern University

6100 Griffin Road, Fort Lauderdale, Florida 33314-4416

PHONE: (954) 262-7726 800-986-3223, Ext. 27726

WEB: nova.edu/chcs 

 Participant Letter for Anonymous Surveys NSU Consent to be in a Research Study Entitled: 

Clinical Practices in Head and Neck Cancer: 

A Speech-Language Pathologist Practice Pattern Survey 

Who is doing this research study? 

The person completing this study is Ashley Geer, MS, CCC-SLP, BCS-S within the Department of Speech-Language Pathology at Nova Southeastern University. They will be helped by Mario Landera, SLP.D, CCC-SLP, BCS-S as faculty advisor. 

Why are you asking me to be in this research study? 

You are being asked to take part in this research study because you are a speech-language pathologist who is involved in the treatment of patients with head and neck cancer. 

Why is this research being done? 

The purpose of this study is to find out the current practice patterns of speech-language pathologists treating patients with head and neck cancer. 

What will I be doing if I agree to be in this research study? 

You will be taking a one-time, anonymous survey. This will take approximately 15 minutes to complete. 

Are there possible risks and discomforts to me? 

This research study involves minimal risk to you. To the best of our knowledge, the things you will be doing have no more risk of harm than you would have in everyday life. 

What happens if I do not want to be in this research study? 

You can decide not to participate in this research and it will not be held against you. You can exit the survey at any time. 

Will it cost me anything? Will I get paid for being in the study? 

There is no cost for participation in this study. Participation is voluntary and no payment will be provided. 

How will you keep my information private? 

Your responses are anonymous. Information we learn about you in this research study will be handled in a confidential manner, within the limits of the law. No personal identifying information will be collected. The data will be available to the research, the Institutional Review Board and other representatives of this institution, and any granting agencies (if applicable). All confidential data will be kept securely in a password protected file on a password protected computer. All data will be kept for a minimum 36 months from the end of the study and will be destroyed by deletion of electronic records. 

Who can I talk to about the study? 

If you have questions, you can contact Ashley Geer, MS, CCC-SLP, BCS-S at (916) 213-8604 or Mario Landera, SLP.D, CCC-SLP, BCS-S at (305) 243-9479. 

If you have questions about the study but want to talk to someone else who is not a part of the study, you can call the Nova Southeastern University Institutional Review Board (IRB) at (954) 262-5369 or toll free at 1-866-499-0790 or email at IRB@nova.edu. 

Do you understand and do you want to be in the study? 

If you have read the above information and voluntarily wish to participate in this research study, please follow this link: https://www.surveymonkey.com/r/9CK2FKY 



Share this post: ×

Paid Research Opportunity

Living with COPD?

We are looking for adults with COPD to help us to better understand the influence of COPD on eating and drinking.

continue reading →